The Directorate General of Foreign Trade (DGFT) notified by Public Notice No. 3 12023 to extend the date for implementation of the Track and Trace system for the export of drug formulations for maintaining the Parent-Child relationship in packaging levels and it’s uploading on Central Portal has been extended upto 01.08.2023 for both SSI and non-SSI manufactured drugs.
A track & trace system is a software-based solution to track vehicles, loading units, shipments or products throughout the entire supply chain, from supplier to consumer.
In exercise of the powers conferred under Paragraph 2.04 of the Foreign Trade Policy, 2015-20, as amended from time to time, the Director General of Foreign Trade hereby amends Para 2.90A of Handbook of Procedure- 2015-20, as notified vide Public Notice No. 43/2015-20 dated December 05, 2017, read with Public Notice No. 52/2015-20 dated January 05, 2016, Public Notice No. 05/2015-20 dated May 09, 2018, Public Notice No. 43/2015- 2020 dated November 01, 2018, Public Notice No. 16/2015- 2020 dated July 04, 2019, Public Notice No. 66/2015- 2020 dated March 30, 2020, Public Notice No. 16/2015-2020 dated September 22, 2020, Public Notice No. 46/2015-20 dated March 30, 2021, and Public Notice No. 01/2015-2020 dated January 04, 2022, on laying down the procedure for implementation of the Track and Trace system for export consignments of drug formulations.
In Para 2.90 A (vi) and (vii) of Handbook of Procedure – 2015-20 (as amended vide Public Notice No. 01/2015-2020 dated January.
The date for implementation of the Track and Trace system for export of drug formulations with respect to maintaining the Parent-Child relationship in packaging levels and it’s uploading on Central Portal has been extended up to August 01, 2023, for both SSI and non-SSI manufactured drugs.
Subscribe Taxscan Premium to view the JudgmentSupport our journalism by subscribing to Taxscan premium. Follow us on Telegram for quick updates
